Lapatinib for inflammatory breast cancer

Peter Hall; Andrew Hanby; David A Cameron

doi:10.1016/S1470-2045(09)70120-2

Lapatinib for inflammatory breast cancer

Peter Hall, Andrew Hanby, David A Cameron

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	538-9
Number of pages	2
Journal	The Lancet Oncology
Volume	10
Issue number	6
DOIs	https://doi.org/10.1016/S1470-2045(09)70120-2
Publication status	Published - 2009

Keywords / Materials (for Non-textual outputs)

Antineoplastic Agents
Breast Neoplasms
Female
Genes, erbB-2
Humans
Inflammation
Quinazolines

Access to Document

10.1016/S1470-2045(09)70120-2

Cite this

@article{24308b772e2a46f1a97837164590af27,

title = "Lapatinib for inflammatory breast cancer",

keywords = "Antineoplastic Agents, Breast Neoplasms, Female, Genes, erbB-2, Humans, Inflammation, Quinazolines",

author = "Peter Hall and Andrew Hanby and Cameron, {David A}",

year = "2009",

doi = "10.1016/S1470-2045(09)70120-2",

language = "English",

volume = "10",

pages = "538--9",

journal = "The Lancet Oncology",

issn = "1474-5488",

publisher = "Lancet Publishing Group",

number = "6",

}

TY - JOUR

T1 - Lapatinib for inflammatory breast cancer

AU - Hall, Peter

AU - Hanby, Andrew

AU - Cameron, David A

PY - 2009

Y1 - 2009

KW - Antineoplastic Agents

KW - Breast Neoplasms

KW - Female

KW - Genes, erbB-2

KW - Humans

KW - Inflammation

KW - Quinazolines

U2 - 10.1016/S1470-2045(09)70120-2

DO - 10.1016/S1470-2045(09)70120-2

M3 - Article

C2 - 19482243

SN - 1474-5488

VL - 10

SP - 538

EP - 539

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 6

ER -